LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Videos & Transcripts
Capitol Directory (Beta)
US
Missouri MO
Legislatures
2022 Regular Session
Senate
Bills
SB1037
MO
Missouri Senate Bill SB1037
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Meeting Schedule
Missouri 2022 Regular Session
Missouri Senate Bill SB1037
Introduced
1/10/22
Refer
3/1/22
Caption
Modifies provisions relating to naltrexone hydrochloride
Latest SB1037 Activity
Companion Bills
No companion bills found.
Similar Bills
CA AB2256
Law enforcement agencies: opioid antagonist.
CA AB24
Emergency response: opioid antagonist kits.
HI HB310
Relating To Opioid Antagonists.
CA SB234
Opioid antagonists: stadiums, concert venues, and amusement parks.
CA AB1166
Liability for opioid antagonist administration.
CA SB472
Pupil health: opioid overdose reversal medication.
MI HB5077
Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.
MS SB2336
Prevention of overdoses; authorize administration of opioid antagonists by certain persons, provide immunity to.